Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SHAREHOLDER ALERT: Weiss Law Reminds APEN, ABMD, BNFT, and FRSH Shareholders About Its Ongoing Investigations

FRSH

NEW YORK, Dec. 5, 2022 /PRNewswire/ --

(PRNewsfoto/WeissLaw LLP)

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Apollo Endosurgery, Inc. (NASDAQ: APEN)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Apollo Endosurgery, Inc. (NASDAQ: APEN), in connection with the proposed acquisition of APEN by Boston Scientific Corporation. Under the terms of the merger agreement, APEN shareholders will receive $10.00 in cash for each share of APEN common stock owned. If you own APEN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/apen

Abiomed, Inc. (NASDAQ: ABMD)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Abiomed, Inc. (NASDAQ: ABMD), in connection with its proposed tender offer by Johnson & Johnson. Under the tender offer, ABMD shareholders will receive $380.00 in cash, reflecting an enterprise value of approximately $16.6 billion, and a non-tradeable contingent value right (CVR) entitling the holder to receive up to $35.00 for each share of ABMD common stock owned. If you own ABMD shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/abmd

Benefitfocus, Inc. (NASDAQ: BNFT)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Benefitfocus, Inc. (NASDAQ: BNFT), in connection with the proposed acquisition of BNFT by Voya Financial, Inc. Under the terms of the merger agreement, BNFT shareholders will receive $10.50 in cash for each share of BNFT common stock owned. If you own BNFT shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/bnft

Freshworks Inc. (NASDAQ: FRSH)

Weiss Law, a national shareholder rights law firm, is investigating possible breaches of fiduciary duty and violations of the federal securities laws by, among others, the Board of Directors and senior officers of Freshworks Inc. (NASDAQ: FRSH) concerning misleading statements and omissions connected with the company's initial public offering ("IPO"). If you own FRSH shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/frsh

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-apen-abmd-bnft-and-frsh-shareholders-about-its-ongoing-investigations-301694944.html

SOURCE Weiss Law